160 related articles for article (PubMed ID: 6977032)
1. The Jo-1 antibody system in myositis: relationships to clinical features and HLA.
Arnett FC; Hirsch TJ; Bias WB; Nishikai M; Reichlin M
J Rheumatol; 1981; 8(6):925-30. PubMed ID: 6977032
[TBL] [Abstract][Full Text] [Related]
2. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
3. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
4. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
Goldstein R; Duvic M; Targoff IN; Reichlin M; McMenemy AM; Reveille JD; Warner NB; Pollack MS; Arnett FC
Arthritis Rheum; 1990 Aug; 33(8):1240-8. PubMed ID: 1975177
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR4 antigen and IgM rheumatoid factors.
Queirós MV; Sancho MR; Caetano JM
J Rheumatol; 1982; 9(3):370-3. PubMed ID: 6981703
[TBL] [Abstract][Full Text] [Related]
7. The type I interferon system in idiopathic inflammatory myopathies.
Lundberg IE; Helmers SB
Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary report on the clinical application of anti-Jo-1 antibody].
Dong Y; Cheng PC; Zhang NC
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
[TBL] [Abstract][Full Text] [Related]
10. [Cytoplasmic staining pattern characteristic for anti Jo-1 antibody in HEp-2 cells].
Nagano Y; Yoshinoya S; Ohkubo A
Rinsho Byori; 1991 Mar; 39(3):269-72. PubMed ID: 1711130
[TBL] [Abstract][Full Text] [Related]
11. Immunoserological aspects of idiopathic inflammatory muscle disease.
Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
[TBL] [Abstract][Full Text] [Related]
12. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
13. HLA-D related (DR) antigens in various kinds of myositis.
Hirsch TJ; Enlow RW; Bias WB; Arnett FC
Hum Immunol; 1981 Oct; 3(2):181-6. PubMed ID: 6948801
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
Zheng WJ; Wei W; Tang FL
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
[TBL] [Abstract][Full Text] [Related]
15. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
16. Subacute cutaneous lupus erythematosus.
Gilliam JN; Sontheimer RD
Clin Rheum Dis; 1982 Aug; 8(2):343-52. PubMed ID: 6754230
[No Abstract] [Full Text] [Related]
17. [Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain].
Camps García MT; Ocón Sánchez P; Alonso Ortiz A; Belmonte López MA; García Portales R; Frutos Sanz MA; Guil García M; de Ramón Garrido E
Med Clin (Barc); 1994 May; 102(18):688-93. PubMed ID: 8028418
[TBL] [Abstract][Full Text] [Related]
18. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetics of inflammatory myopathies.
Garlepp MJ
Baillieres Clin Neurol; 1993 Nov; 2(3):579-97. PubMed ID: 8156144
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG;
Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
